A South Korean research team is developing an anticancer technology that selectively targets DNA mutations found only in ...

About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...

Stand Up To Cancer® (SU2C) today announced the recipients of the SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award. The approximately $225,000 in award funding will support a multi ...

Cancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different genetic paths. A new study shows that these differences can sometimes be traced ...

Chromosome 13q linkage promotes RB1 hemizygosity during BRCA2 LOH, lowering the ‘two-hit’ barrier and predisposing to acquired RB1 inactivation on CDK4/6 inhibition. Large genomic study shows BRCA2 ...

Dr. Stacy Norton was only 7 years old when her mother died of colon cancer, one of several family members struck by ...

A single sperm donor who carries a rare cancer-causing genetic mutation has fathered at least 197 children across 14 countries in Europe, according to a collaborative investigation by 14 European news ...

Scientists are testing experimental Lynch syndrome vaccines designed to prevent colon cancer before tumors form.

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene mutation behaves differently from other variants. The study, published in ...